{"transactions":[{"id":4627516,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B-2 Preferred Stock","published_at":"2026-09-28T20:05:13.000Z","date":"2024-08-12","kind":"exercise","planned":false,"acquired":false,"shares":30,"price":1000,"value":30000.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1000,"exercise_date":"2023-05-04","expiration_date":"2024-08-04","underlying":"Common Stock","underlying_shares":579},"source":{"system":"sec-edgar","filing":"0001104659-26-111343","document":"tm2626098-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465926111343/tm2626098-1_4seq1.xml","form_type":"4"}},{"id":4627515,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-28T20:05:13.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":297000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period."}],"balance_after":454432,"source":{"system":"sec-edgar","filing":"0001104659-26-111343","document":"tm2626098-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465926111343/tm2626098-1_4seq1.xml","form_type":"4"}},{"id":4627514,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-28T20:05:13.000Z","date":"2024-08-12","kind":"exercise","planned":false,"acquired":true,"shares":579,"price":19.1,"value":11058.9,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person's 30 shares of Series B-2 Preferred Stock automatically converted into 11,574 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 579 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 157,432 shares of Common Stock immediately following the conversion."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person's 30 shares of Series B-2 Preferred Stock automatically converted into 11,574 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 579 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 157,432 shares of Common Stock immediately following the conversion."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's 30 shares of Series B-2 Preferred Stock automatically converted into 11,574 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 579 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 157,432 shares of Common Stock immediately following the conversion."}],"balance_after":157432,"source":{"system":"sec-edgar","filing":"0001104659-26-111343","document":"tm2626098-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465926111343/tm2626098-1_4seq1.xml","form_type":"4"}},{"id":1040470,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-15T16:08:08.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025."}],"balance_after":156853,"source":{"system":"sec-edgar","filing":"0001104659-25-090006","document":"tm2526001-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465925090006/tm2526001-7_4seq1.xml","form_type":"4"}},{"id":1420866,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-28T18:12:05.000Z","date":"2024-08-27","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.88,"value":4400.0,"ownership":{"direct":true},"balance_after":1937059,"source":{"system":"sec-edgar","filing":"0001104659-24-094109","document":"tm2422950-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465924094109/tm2422950-1_4seq1.xml","form_type":"4"}},{"id":1424245,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-23T16:05:20.000Z","date":"2024-08-21","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.95,"value":4750.0,"ownership":{"direct":true},"balance_after":1932059,"source":{"system":"sec-edgar","filing":"0001104659-24-092417","document":"tm2422584-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465924092417/tm2422584-1_4seq1.xml","form_type":"4"}},{"id":1424244,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-23T16:05:20.000Z","date":"2024-08-20","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.93,"value":4650.0,"ownership":{"direct":true},"balance_after":1927059,"source":{"system":"sec-edgar","filing":"0001104659-24-092417","document":"tm2422584-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465924092417/tm2422584-1_4seq1.xml","form_type":"4"}},{"id":1427654,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-20T16:01:15.000Z","date":"2024-08-19","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9,"value":4500.0,"ownership":{"direct":true},"balance_after":1922059,"source":{"system":"sec-edgar","filing":"0001104659-24-091264","document":"tm2422157-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465924091264/tm2422157-1_4seq1.xml","form_type":"4"}},{"id":1427653,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-20T16:01:15.000Z","date":"2024-08-16","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":0.9,"value":2700.0,"ownership":{"direct":true},"balance_after":1917059,"source":{"system":"sec-edgar","filing":"0001104659-24-091264","document":"tm2422157-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465924091264/tm2422157-1_4seq1.xml","form_type":"4"}},{"id":1427652,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-20T16:01:15.000Z","date":"2024-08-16","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":0.89,"value":1780.0,"ownership":{"direct":true},"balance_after":1914059,"source":{"system":"sec-edgar","filing":"0001104659-24-091264","document":"tm2422157-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465924091264/tm2422157-1_4seq1.xml","form_type":"4"}},{"id":1586771,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-08T16:19:38.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in quarterly instalments on the last day of each calendar quarter commencing March 31, 2024 for a two year period."}],"balance_after":1912059,"source":{"system":"sec-edgar","filing":"0001104659-24-032409","document":"tm248350-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465924032409/tm248350-4_4seq1.xml","form_type":"4"}},{"id":1900944,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B-2 Preferred Stock","published_at":"2023-05-08T16:11:15.000Z","date":"2023-05-04","kind":"purchase","planned":false,"acquired":true,"shares":30,"price":1000,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series B Preferred Stock will automatically convert into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Series B Preferred Stock initially converts into shares of common stock at a conversion price of $3.37. In addition, the holders of Series B Preferred Stock will also be entitled dividends payable as follows: (i) a number of shares of Common Stock equal to five percent (5.0%) of the number of shares of Common Stock issuable upon conversion of the Series B Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the closing date, and (ii) a number of shares of common stock equal to ten percent (10%) of the number of shares of common stock issuable upon conversion of the Series B Preferred Stock then held by such holder on the fifth full quarter from the closing date."}],"balance_after":30,"derivative":{"exercise_price":3.37,"exercise_date":"2023-05-04","expiration_date":"2026-05-04","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001104659-23-057156","document":"tm2315002-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465923057156/tm2315002-1_4seq1.xml","form_type":"4"}},{"id":2052461,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-18T17:01:55.000Z","date":"2023-01-13","kind":"sale","acquired":false,"shares":1200,"price":6.2075,"value":7449.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.20 to $6.23, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":1112059,"source":{"system":"sec-edgar","filing":"0001104659-23-004642","document":"tm233645-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465923004642/tm233645-1_4seq1.xml","form_type":"4"}},{"id":2261834,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-20T17:02:08.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares vest over three years as follows: 8.333% shall vest after 3 months from the grant date, and the remaining shares vest in 11 equal instalments every 3 months thereafter."}],"balance_after":1113259,"source":{"system":"sec-edgar","filing":"0001104659-22-063450","document":"tm2216123-5_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465922063450/tm2216123-5_4seq.xml","form_type":"4"}},{"id":2519629,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-09T20:51:54.000Z","date":"2021-11-08","kind":"sale","acquired":false,"shares":800,"price":19.0788,"value":15263.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.19, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."}],"balance_after":838259,"source":{"system":"sec-edgar","filing":"0001104659-21-136496","document":"tm2132400d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921136496/tm2132400d1_4.xml","form_type":"4"}},{"id":2519628,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-09T20:51:54.000Z","date":"2021-11-05","kind":"sale","acquired":false,"shares":200,"price":19.05,"value":3810.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.09, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":839059,"source":{"system":"sec-edgar","filing":"0001104659-21-136496","document":"tm2132400d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921136496/tm2132400d1_4.xml","form_type":"4"}},{"id":2523012,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-05T19:00:38.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":7857,"price":18.4907,"value":145281.4299,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.02 to $19.10, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."}],"balance_after":839259,"source":{"system":"sec-edgar","filing":"0001104659-21-135188","document":"tm2132090-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921135188/tm2132090-1_4seq1.xml","form_type":"4"}},{"id":2523011,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-05T19:00:38.000Z","date":"2021-11-03","kind":"sale","acquired":false,"shares":30483,"price":18.9648,"value":578103.9984,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.40 to $19.38, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":847116,"source":{"system":"sec-edgar","filing":"0001104659-21-135188","document":"tm2132090-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921135188/tm2132090-1_4seq1.xml","form_type":"4"}},{"id":2526336,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-03T19:00:30.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":41279,"price":18.6648,"value":770464.2792,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.52 to $19.16, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."}],"balance_after":877599,"source":{"system":"sec-edgar","filing":"0001104659-21-133842","document":"tm2131828-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921133842/tm2131828-1_4seq1.xml","form_type":"4"}},{"id":2526335,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-03T19:00:30.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":25804,"price":18.0098,"value":464724.8792,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.50 to $18.35, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":918878,"source":{"system":"sec-edgar","filing":"0001104659-21-133842","document":"tm2131828-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921133842/tm2131828-1_4seq1.xml","form_type":"4"}},{"id":2544500,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-12T16:46:20.000Z","date":"2021-10-10","kind":"grant","acquired":true,"shares":695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2021."}],"balance_after":944682,"source":{"system":"sec-edgar","filing":"0001104659-21-125373","document":"tm2129692d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921125373/tm2129692d2_4.xml","form_type":"4"}},{"id":2629214,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-20T16:31:05.000Z","date":"2021-07-18","kind":"grant","acquired":true,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the third quarter of 2021."}],"balance_after":943987,"source":{"system":"sec-edgar","filing":"0001104659-21-093983","document":"tm2122591-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921093983/tm2122591-2_4seq1.xml","form_type":"4"}},{"id":2630564,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-19T17:51:57.000Z","date":"2021-07-15","kind":"sale","acquired":false,"shares":1300,"price":17.6255,"value":22913.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.50 to $17.78, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":943299,"source":{"system":"sec-edgar","filing":"0001104659-21-093563","document":"tm2122533-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921093563/tm2122533-1_4seq1.xml","form_type":"4"}},{"id":2703185,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Grant","published_at":"2021-05-20T16:10:58.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":413158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"The shares vest over three years as follows: 8.333% shall vest on March 31, 2021, and the remaining shares vest in 11 equal instalments every 3 months thereafter."}],"balance_after":943926,"source":{"system":"sec-edgar","filing":"0001104659-21-069894","document":"tm2117107d1_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921069894/tm2117107d1_4a.xml","form_type":"4/A","original_submission_date":"2021-01-22"}},{"id":2703184,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-20T16:10:58.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":2268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2021."}],"balance_after":530768,"source":{"system":"sec-edgar","filing":"0001104659-21-069894","document":"tm2117107d1_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921069894/tm2117107d1_4a.xml","form_type":"4/A","original_submission_date":"2021-01-22"}},{"id":2727302,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-05T16:06:17.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the second quarter of 2021."}],"balance_after":944599,"source":{"system":"sec-edgar","filing":"0001104659-21-061708","document":"tm2115112d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921061708/tm2115112d2_4seq1.xml","form_type":"4"}},{"id":2900756,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Grant","published_at":"2021-01-21T16:08:19.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":413158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"The shares vest over three years as follows: 8.333% shall vest on March 31, 2021, and the remaining shares vest in 11 equal instalments every 3 months thereafter."}],"balance_after":943926,"source":{"system":"sec-edgar","filing":"0001104659-21-006294","document":"tm213677-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921006294/tm213677-6_4seq1.xml","form_type":"4"}},{"id":2900755,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-21T16:08:19.000Z","date":"2021-01-19","kind":"purchase","acquired":true,"shares":2268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2021."}],"balance_after":530768,"source":{"system":"sec-edgar","filing":"0001104659-21-006294","document":"tm213677-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921006294/tm213677-6_4seq1.xml","form_type":"4"}},{"id":3002897,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-10-20T16:09:16.000Z","date":"2020-10-16","kind":"purchase","acquired":true,"shares":7187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2020, and for additional compensation waived between April 2020 and July 2020"}],"balance_after":528500,"source":{"system":"sec-edgar","filing":"0001104659-20-116435","document":"tm2033754d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465920116435/tm2033754d4_4.xml","form_type":"4"}},{"id":3077849,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-07-22T16:10:32.000Z","date":"2020-07-20","kind":"purchase","acquired":true,"shares":15593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the third quarter of 2020."}],"balance_after":521313,"source":{"system":"sec-edgar","filing":"0001104659-20-085626","document":"tm2025176d5_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465920085626/tm2025176d5_4.xml","form_type":"4"}},{"id":3116396,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-09T16:05:21.000Z","date":"2020-06-09","kind":"purchase","acquired":true,"shares":500,"price":6.06,"value":3030.0,"ownership":{"direct":true},"balance_after":505720,"source":{"system":"sec-edgar","filing":"0001104659-20-071369","document":"tm2022156d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465920071369/tm2022156d1_4.xml","form_type":"4"}},{"id":3116395,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-09T16:05:21.000Z","date":"2020-06-08","kind":"purchase","acquired":true,"shares":500,"price":5.98,"value":2990.0,"ownership":{"direct":true},"balance_after":505220,"source":{"system":"sec-edgar","filing":"0001104659-20-071369","document":"tm2022156d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465920071369/tm2022156d1_4.xml","form_type":"4"}},{"id":3180667,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-04-07T16:06:28.000Z","date":"2020-04-03","kind":"purchase","acquired":true,"shares":15146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the second quarter of 2020."}],"balance_after":504720,"source":{"system":"sec-edgar","filing":"0001104659-20-044154","document":"tm2015091d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465920044154/tm2015091d4_4.xml","form_type":"4"}},{"id":3195337,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-25T17:07:09.000Z","date":"2020-03-25","kind":"purchase","acquired":true,"shares":1000,"price":6.38,"value":6380.0,"ownership":{"direct":true},"balance_after":489574,"source":{"system":"sec-edgar","filing":"0001104659-20-038347","document":"tm2013824-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465920038347/tm2013824-1_4.xml","form_type":"4"}},{"id":3270738,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-14T16:15:18.000Z","date":"2020-02-12","kind":"purchase","acquired":true,"shares":351546,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":488574,"source":{"system":"sec-edgar","filing":"0001104659-20-021767","document":"tm207834-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465920021767/tm207834-1_4.xml","form_type":"4"}},{"id":3297743,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-30T16:07:54.000Z","date":"2020-01-28","kind":"purchase","acquired":true,"shares":15602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2020."}],"balance_after":137028,"source":{"system":"sec-edgar","filing":"0001104659-20-008689","document":"tm206156d8_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465920008689/tm206156d8_4.xml","form_type":"4"}},{"id":3331293,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-12-26T16:06:03.000Z","date":"2019-12-23","kind":"purchase","acquired":true,"shares":15454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2019 in the aggregate amount of $66,610.47."}],"balance_after":121426,"source":{"system":"sec-edgar","filing":"0001104659-19-076115","document":"tm1927375-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465919076115/tm1927375-2_4.xml","form_type":"4"}},{"id":3427401,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-08-28T16:05:31.000Z","date":"2019-08-28","kind":"purchase","acquired":true,"shares":10000,"price":0.349,"value":3490.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":2119398,"source":{"system":"sec-edgar","filing":"0001144204-19-042086","document":"tv528532_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420419042086/tv528532_4.xml","form_type":"4"}},{"id":3464177,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-07-10T16:05:46.000Z","date":"2019-07-09","kind":"purchase","acquired":true,"shares":214952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the second and third quarters of 2019 in the aggregate amount of $128,972."}],"balance_after":2109398,"source":{"system":"sec-edgar","filing":"0001144204-19-034297","document":"tv524960_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420419034297/tv524960_4.xml","form_type":"4"}},{"id":3545582,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-30T17:01:07.000Z","date":"2019-04-29","kind":"purchase","acquired":true,"shares":497010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Of the amount shown, 89,429 shares were awarded in lieu of a cash bonus compensation for the fiscal year of 2018 in the amount of $89,429.75."}],"balance_after":1894446,"source":{"system":"sec-edgar","filing":"0001144204-19-022458","document":"tv520227_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420419022458/tv520227_4.xml","form_type":"4"}},{"id":3683863,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-29T16:03:38.000Z","date":"2019-01-27","kind":"purchase","acquired":true,"shares":61969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2019 in the amount of $61,969.43."}],"balance_after":1397436,"source":{"system":"sec-edgar","filing":"0001144204-19-003515","document":"tv511869_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420419003515/tv511869_4.xml","form_type":"4"}},{"id":3754690,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-11-21T16:01:39.000Z","date":"2018-11-20","kind":"purchase","acquired":true,"shares":4000,"price":0.84,"value":3360.0,"ownership":{"direct":true},"balance_after":1335467,"source":{"system":"sec-edgar","filing":"0001144204-18-061226","document":"tv507710_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420418061226/tv507710_4.xml","form_type":"4"}},{"id":3796016,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-10-05T16:21:40.000Z","date":"2018-10-03","kind":"grant","acquired":true,"shares":64392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2018 in the amount of $64,002.62."}],"balance_after":1331467,"source":{"system":"sec-edgar","filing":"0001144204-18-052744","document":"tv504212_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420418052744/tv504212_form4.xml","form_type":"4"}},{"id":3870376,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-07-10T16:05:36.000Z","date":"2018-07-09","kind":"grant","acquired":true,"shares":49942,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the second quarter of 2018 in the amount of $8,880.49, and for the third quarter of 2018 in the amount of $63,844.19."}],"balance_after":1267075,"source":{"system":"sec-edgar","filing":"0001144204-18-037836","document":"tv498254_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420418037836/tv498254_form4.xml","form_type":"4"}},{"id":3900083,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-06-08T16:06:38.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":706294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Of the amount shown, 56,880 shares were awarded in lieu of a cash bonus compensation for the fiscal year of 2017 in the amount of $98,345.06."}],"balance_after":1217133,"source":{"system":"sec-edgar","filing":"0001144204-18-033542","document":"tv496161_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420418033542/tv496161_4.xml","form_type":"4"}},{"id":3957210,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-04-25T16:13:49.000Z","date":"2018-04-23","kind":"grant","acquired":true,"shares":25536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the second quarter of 2018 in the amount of $39,344.17."}],"balance_after":510839,"source":{"system":"sec-edgar","filing":"0001144204-18-022388","document":"tv491870_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420418022388/tv491870_4.xml","form_type":"4"}},{"id":4104274,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-01-08T16:17:36.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":25439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2018 in the amount of $39,922.93."}],"balance_after":485303,"source":{"system":"sec-edgar","filing":"0001144204-18-001309","document":"tv482699_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420418001309/tv482699_4.xml","form_type":"4"}},{"id":4180682,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-10-25T16:08:56.000Z","date":"2017-10-23","kind":"grant","acquired":true,"shares":21128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2017 in the amount of $39,221.54."}],"balance_after":459864,"source":{"system":"sec-edgar","filing":"0001144204-17-054100","document":"tv477613_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420417054100/tv477613_4.xml","form_type":"4"}},{"id":4259110,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-07-11T16:10:08.000Z","date":"2017-07-10","kind":"grant","acquired":true,"shares":17036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the third quarter of 2017 in the amount of $39,388.96."}],"balance_after":438736,"source":{"system":"sec-edgar","filing":"0001144204-17-036442","document":"v470582_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420417036442/v470582_4.xml","form_type":"4"}},{"id":4347735,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-04-21T16:16:04.000Z","date":"2017-04-20","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities as a bonus for the 2016 fiscal year."}],"balance_after":421700,"source":{"system":"sec-edgar","filing":"0001144204-17-021534","document":"v464822_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420417021534/v464822_form4.xml","form_type":"4"}},{"id":4351558,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-04-17T16:26:01.000Z","date":"2017-04-13","kind":"grant","acquired":true,"shares":10369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the second quarter of 2017 in the amount of $37,952.51."}],"balance_after":371700,"source":{"system":"sec-edgar","filing":"0001144204-17-020723","document":"v464390_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420417020723/v464390_4.xml","form_type":"4"}},{"id":4473611,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-01T16:07:00.000Z","date":"2017-01-30","kind":"grant","acquired":true,"shares":143164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in twelve equal quarterly installments commencing on January 30, 2017."}],"balance_after":143164,"derivative":{"exercise_price":3.202,"expiration_date":"2023-01-30","underlying":"Common Stock","underlying_shares":143164},"source":{"system":"sec-edgar","filing":"0001144204-17-005358","document":"v457885_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420417005358/v457885_4.xml","form_type":"4"}},{"id":4473610,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-01T16:07:00.000Z","date":"2017-01-30","kind":"grant","acquired":true,"shares":11381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2017 in the amount of $36,443.60."}],"balance_after":361331,"source":{"system":"sec-edgar","filing":"0001144204-17-005358","document":"v457885_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420417005358/v457885_4.xml","form_type":"4"}},{"id":4473609,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-01T16:07:00.000Z","date":"2017-01-30","kind":"grant","acquired":true,"shares":227616,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":349950,"source":{"system":"sec-edgar","filing":"0001144204-17-005358","document":"v457885_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420417005358/v457885_4.xml","form_type":"4"}},{"id":4491151,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-13T16:42:27.000Z","date":"2017-01-12","kind":"grant","acquired":true,"shares":11205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2016 in the amount of $35,960.72."}],"balance_after":122334,"source":{"system":"sec-edgar","filing":"0001144204-17-002214","document":"v456901_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000114420417002214/v456901_4.xml","form_type":"4"}}]}